FDA Guidance for Industry: Q3D(R2) ELEMENTAL IMPURITIES

Titel:
FDA Guidance for Industry: Q3D(R2) ELEMENTAL IMPURITIES
Internet:

https://www.gmp-navigator.com/files/guidemgr/38535536_Q3D(R2) Draft Guideline.pdf

Herkunft/Verlag:

FDA, https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM613410.pdf

Inhalt:
Because elemental impurities do not provide any therapeutic benefit to the patient, their levels in the drug product should be controlled within acceptable limits.

Zurück